1. Achterrath, W., Niederle, TV., Raettig, R., Hilgard, P: Etoposide - chem- istry, preclinical and clinical pharmacology. Cancer Treat. Rev. 9 (Suppl. A), 3–13 (1982).
2. Calman, F., Bellamy, D., Farebrother, M., Timothy, A., Bateman, TV., Rubens, R., Costello, J: High-dose VP 16-213 with Vincristine and Adriamycin in the treatment of small-cell lung cancer (SCLC). Europ. J. Resp. Dis. 63 (Suppl. 125), 81 (1982).
3. Eagan, R. T: Etoposide alone and in combination with cyclophosphami- de, adriamycin and cis-platinum in patients with M0 and M1 non-small-cell lung cancer. Cancer Treat. Rev. 9 (Suppl. A), 119–131 (1982).
4. Eagan, R. T., Ingle, J. TV., Creagan, E.T., Frytak, S., ZfrWs, L. K, Rubin, J., McMahon, T: VP 16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung. Cancer Treat. Rep. 62, 843–844 (1978).
5. Goldhirsch, A., Joss, R., Cavalli, F., Sonntag, R. W., Ryssel, H.J., Brunner, K. W: Etoposid. Dtsch. med. Wschr. 106, 1105–1109 (1981).